Over the past year, numerous studies in the peer reviewed and preprint literature have
reported on the virological, epidemiological and clinical characteristics of the coronavirus …

SARS-CoV-2 is an RNA virus that was identified for the first time in December 2019 in
Wuhan, China. The World Health Organization (WHO) labeled the novel coronavirus …

SARS‐CoV‐2 acute respiratory distress syndrome (ARDS) induces uncontrolled lung
inflammation and coagulopathy with high mortality. Anti‐viral drugs and monoclonal …

The precise interaction between the immune system and severe acute respiratory syndrome
coronavirus 2 (SARS‑CoV‑2) is critical in deciphering the pathogenesis of coronavirus …

Understanding the T cell response to SARS-CoV-2 is critical to vaccine development,
epidemiological surveillance, and control strategies for this disease. This review provides …

Human leukocyte antigen (HLA) class I peptide ligands (HLAIps) are key targets for
developing vaccines and immunotherapies against infectious pathogens or cancer cells …

Background The long-term course of immunity among individuals with a history of COVID-
19, in particular among those who received a booster vaccination, has not been well defined …

The COVID-19 pandemic has affected millions of people and posed an unprecedented
burden on healthcare systems and economies worldwide since the outbreak of the COVID …

An efficient host immune response is crucial in controlling viral infections. Despite most
studies focused on the implication of T and B cell response in COVID-19 (Corona Virus …

Background: During the COVID-19 pandemic, working age individuals have been implicated
in sustaining the resurgence of SARS-CoV-2 infections, and multiple outbreaks have been …